Atul Tantia files SEBI Reg 31(4) substantial acquisition disclosure for GPT Healthcare

M&A / JV 29 Jun 2026 · Announced· ✓ Verified

Atul Tantia, via NSE filing dated 29 Jun 2026, submitted disclosure under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Regulation 31(4). This regulation mandates disclosure when a person acquires shares or voting rights exceeding prescribed thresholds (typically 5%). The filing establishes that the acquirer has met disclosure obligations to the stock exchange and the public, a prerequisite for any subsequent open offer or negotiated transaction in a pharma company listed on NSE.

Why it mattersThe filing of Reg 31(4) confirms crossing of the 5% threshold under SEBI Takeover Regulations; the acquirer's identity and timing trigger board approval, public announcement, and potential open offer obligations-key gating items for any listed pharma M&A.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals